Bisphosphonates as Anticancer Therapy for Early Breast Cancer

Reshma Mahtani; Mohammad Jahanzeb

Bisphosphonates as Anticancer Therapy for Early Breast Cancer

Miami Cancer Institute

Research output: Contribution to journal › Article › peer-review

Original language	American English
Journal	Clinical Breast Cancer
Volume	10
State	Published - 2010

Disciplines

Medicine and Health Sciences

Cite this

@article{907e5d70651d47b49f4d6dd700fa1c0f,

title = "Bisphosphonates as Anticancer Therapy for Early Breast Cancer",

author = "Reshma Mahtani and Mohammad Jahanzeb",

note = "Bisphosphonates (BPs) are approved for preventing the skeletal-related events associated with malignant bone disease. Several studies indicate that they may also prevent cancer therapy-induced bone loss. Multiple preclinical and early clinical studies provide evidence of the anticancer activity of B ...",

year = "2010",

language = "American English",

volume = "10",

journal = "Clinical Breast Cancer",

}

TY - JOUR

T1 - Bisphosphonates as Anticancer Therapy for Early Breast Cancer

AU - Mahtani, Reshma

AU - Jahanzeb, Mohammad

N1 - Bisphosphonates (BPs) are approved for preventing the skeletal-related events associated with malignant bone disease. Several studies indicate that they may also prevent cancer therapy-induced bone loss. Multiple preclinical and early clinical studies provide evidence of the anticancer activity of B ...

PY - 2010

Y1 - 2010

UR - https://pubmed.ncbi.nlm.nih.gov/20920980/

M3 - Article

VL - 10

JO - Clinical Breast Cancer

JF - Clinical Breast Cancer

ER -

Bisphosphonates as Anticancer Therapy for Early Breast Cancer

Disciplines

Other files and links

Cite this